English
简体中文
Total: £ 56.28
Published Date: 2026-01-13 | Pages: 138 | Tables: 140 | Medical Care
The global cGMP Process Development market was valued at US$ 4108 million in 2025 and is anticipated to reach US$ 6437 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
cGMP process development refers to a series of development activities that systematically design, optimize, scale up, and validate a pharmaceutical manufacturing process under a quality system that complies with current Good Manufacturing Practices (GMP) requirements. The goal is to establish a manufacturable, repeatable, scalable, transferable, and long-term compliant manufacturing process.
Gross Margin Levels
The gross margin for cGMP process development exhibits a clear stratification based on "capability complexity + compliance costs + resource utilization": For highly standardized small molecule process exploration and routine analytical method development, competition is more intense, and gross margins typically fall between 25% and 35%. Integrated CDMOs with platform capabilities and seamless integration with clinical/commercial manufacturing, due to stronger customer loyalty and the ability to deliver packages (development + technology transfer + clinical approval), gross margins are more commonly between 30% and 45%. In high-barrier-to-entry areas such as ADCs, cell and gene therapy, viral vectors, and sterile preparations, constrained by highly skilled personnel, compliance documentation systems, and limited capacity, gross margins can reach 40%–55% if capacity utilization is good. Publicly available comparable metrics show that the industry's commonly disclosed EBITDA margin for CDMO businesses is mostly around 20%–30%+, which also reflects the strong profitability elasticity of this type of service driven by scale and high-value-added projects.
Industry Drivers
The growth of cGMP process development is driven by three converging forces: First, pharmaceutical companies and biotech firms, under pressure to improve financial efficiency and R&D returns, are continuously outsourcing CMC and manufacturing-related work. Many believe that outsourcing growth is likely to outpace overall pharmaceutical growth in the medium term, accelerating the adoption of end-to-end outsourcing models from process development to technology transfer to clinical/commercial manufacturing. Second, the increasing proportion of biologics and novel therapies (such as macromolecules and advanced therapies) is upgrading process development from simply "being able to manufacture" to "scalable, verifiable, and sustainably compliant," placing higher demands on process characterization, QbD, contamination control, and aseptic assurance, thereby increasing the value of individual projects and reliance on outsourcing. Third, changes in the global supply chain and regulatory environment are driving the industry towards a more controllable compliance system and regionalized capacity layout. Leading CDMOs are continuously restructuring and investing around high-value platforms and capacities, further accelerating clients' commitment to binding key process development stages to service providers with global compliance and scalable delivery capabilities.
This report delivers a comprehensive overview of the global cGMP Process Development market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding cGMP Process Development. The cGMP Process Development market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global cGMP Process Development market comprehensively. Regional market sizes by Type, by Application, by Service Phase, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist cGMP Process Development manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Lonza
Thermo Fisher Scientific
Catalent
Samsung Biologics
WuXi Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
Recipharm
Siegfried
Cambrex
WuXi STA
Piramal Pharma Solutions
Evonik Health Care
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Curia
Almac Pharma Services
Segment by Type
Microbial cGMP Manufacturing
Mammalian cGMP Manufacturing
Others
Segment by Service Phase
Preclinical Process Development
Clinical-Stage Process Development
Commercialization Process Development
Segment by Technology Platform
Chemical Synthesis Process Development Platform
Cell Culture Process Development Platform
Others
Segment by Application
Pharmaceutical
Biotechnology
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Service Phase, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for cGMP Process Development companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global cGMP Process Development Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Microbial cGMP Manufacturing
1.2.3 Mammalian cGMP Manufacturing
1.2.4 Others
1.3 Market by Service Phase
1.3.1 Global cGMP Process Development Market Size Growth Rate by Service Phase: 2021 vs 2025 vs 2032
1.3.2 Preclinical Process Development
1.3.3 Clinical-Stage Process Development
1.3.4 Commercialization Process Development
1.4 Market by Technology Platform
1.4.1 Global cGMP Process Development Market Size Growth Rate by Technology Platform: 2021 vs 2025 vs 2032
1.4.2 Chemical Synthesis Process Development Platform
1.4.3 Cell Culture Process Development Platform
1.4.4 Others
1.5 Market by Application
1.5.1 Global cGMP Process Development Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical
1.5.3 Biotechnology
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global cGMP Process Development Market Perspective (2021–2032)
2.2 Global cGMP Process Development Growth Trends by Region
2.2.1 Global cGMP Process Development Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 cGMP Process Development Historic Market Size by Region (2021–2026)
2.2.3 cGMP Process Development Forecasted Market Size by Region (2027–2032)
2.3 cGMP Process Development Market Dynamics
2.3.1 cGMP Process Development Industry Trends
2.3.2 cGMP Process Development Market Drivers
2.3.3 cGMP Process Development Market Challenges
2.3.4 cGMP Process Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Process Development Players by Revenue
3.1.1 Global Top cGMP Process Development Players by Revenue (2021–2026)
3.1.2 Global cGMP Process Development Revenue Market Share by Players (2021–2026)
3.2 Global Top cGMP Process Development Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by cGMP Process Development Revenue
3.4 Global cGMP Process Development Market Concentration Ratio
3.4.1 Global cGMP Process Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Process Development Revenue in 2025
3.5 Global Key Players of cGMP Process Development Head Offices and Areas Served
3.6 Global Key Players of cGMP Process Development, Products and Applications
3.7 Global Key Players of cGMP Process Development, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 cGMP Process Development Breakdown Data by Type
4.1 Global cGMP Process Development Historic Market Size by Type (2021–2026)
4.2 Global cGMP Process Development Forecasted Market Size by Type (2027–2032)
5 cGMP Process Development Breakdown Data by Application
5.1 Global cGMP Process Development Historic Market Size by Application (2021–2026)
5.2 Global cGMP Process Development Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America cGMP Process Development Market Size (2021–2032)
6.2 North America cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America cGMP Process Development Market Size by Country (2021–2026)
6.4 North America cGMP Process Development Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe cGMP Process Development Market Size (2021–2032)
7.2 Europe cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe cGMP Process Development Market Size by Country (2021–2026)
7.4 Europe cGMP Process Development Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific cGMP Process Development Market Size (2021–2032)
8.2 Asia-Pacific cGMP Process Development Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific cGMP Process Development Market Size by Region (2021–2026)
8.4 Asia-Pacific cGMP Process Development Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America cGMP Process Development Market Size (2021–2032)
9.2 Latin America cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America cGMP Process Development Market Size by Country (2021–2026)
9.4 Latin America cGMP Process Development Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Process Development Market Size (2021–2032)
10.2 Middle East & Africa cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa cGMP Process Development Market Size by Country (2021–2026)
10.4 Middle East & Africa cGMP Process Development Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza cGMP Process Development Introduction
11.1.4 Lonza Revenue in cGMP Process Development Business (2021–2026)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific cGMP Process Development Introduction
11.2.4 Thermo Fisher Scientific Revenue in cGMP Process Development Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent cGMP Process Development Introduction
11.3.4 Catalent Revenue in cGMP Process Development Business (2021–2026)
11.3.5 Catalent Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Details
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics cGMP Process Development Introduction
11.4.4 Samsung Biologics Revenue in cGMP Process Development Business (2021–2026)
11.4.5 Samsung Biologics Recent Development
11.5 WuXi Biologics
11.5.1 WuXi Biologics Company Details
11.5.2 WuXi Biologics Business Overview
11.5.3 WuXi Biologics cGMP Process Development Introduction
11.5.4 WuXi Biologics Revenue in cGMP Process Development Business (2021–2026)
11.5.5 WuXi Biologics Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies cGMP Process Development Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in cGMP Process Development Business (2021–2026)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim cGMP Process Development Introduction
11.7.4 Boehringer Ingelheim Revenue in cGMP Process Development Business (2021–2026)
11.7.5 Boehringer Ingelheim Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Details
11.8.2 Recipharm Business Overview
11.8.3 Recipharm cGMP Process Development Introduction
11.8.4 Recipharm Revenue in cGMP Process Development Business (2021–2026)
11.8.5 Recipharm Recent Development
11.9 Siegfried
11.9.1 Siegfried Company Details
11.9.2 Siegfried Business Overview
11.9.3 Siegfried cGMP Process Development Introduction
11.9.4 Siegfried Revenue in cGMP Process Development Business (2021–2026)
11.9.5 Siegfried Recent Development
11.10 Cambrex
11.10.1 Cambrex Company Details
11.10.2 Cambrex Business Overview
11.10.3 Cambrex cGMP Process Development Introduction
11.10.4 Cambrex Revenue in cGMP Process Development Business (2021–2026)
11.10.5 Cambrex Recent Development
11.11 WuXi STA
11.11.1 WuXi STA Company Details
11.11.2 WuXi STA Business Overview
11.11.3 WuXi STA cGMP Process Development Introduction
11.11.4 WuXi STA Revenue in cGMP Process Development Business (2021–2026)
11.11.5 WuXi STA Recent Development
11.12 Piramal Pharma Solutions
11.12.1 Piramal Pharma Solutions Company Details
11.12.2 Piramal Pharma Solutions Business Overview
11.12.3 Piramal Pharma Solutions cGMP Process Development Introduction
11.12.4 Piramal Pharma Solutions Revenue in cGMP Process Development Business (2021–2026)
11.12.5 Piramal Pharma Solutions Recent Development
11.13 Evonik Health Care
11.13.1 Evonik Health Care Company Details
11.13.2 Evonik Health Care Business Overview
11.13.3 Evonik Health Care cGMP Process Development Introduction
11.13.4 Evonik Health Care Revenue in cGMP Process Development Business (2021–2026)
11.13.5 Evonik Health Care Recent Development
11.14 AGC Biologics
11.14.1 AGC Biologics Company Details
11.14.2 AGC Biologics Business Overview
11.14.3 AGC Biologics cGMP Process Development Introduction
11.14.4 AGC Biologics Revenue in cGMP Process Development Business (2021–2026)
11.14.5 AGC Biologics Recent Development
11.15 Rentschler Biopharma
11.15.1 Rentschler Biopharma Company Details
11.15.2 Rentschler Biopharma Business Overview
11.15.3 Rentschler Biopharma cGMP Process Development Introduction
11.15.4 Rentschler Biopharma Revenue in cGMP Process Development Business (2021–2026)
11.15.5 Rentschler Biopharma Recent Development
11.16 KBI Biopharma
11.16.1 KBI Biopharma Company Details
11.16.2 KBI Biopharma Business Overview
11.16.3 KBI Biopharma cGMP Process Development Introduction
11.16.4 KBI Biopharma Revenue in cGMP Process Development Business (2021–2026)
11.16.5 KBI Biopharma Recent Development
11.17 Curia
11.17.1 Curia Company Details
11.17.2 Curia Business Overview
11.17.3 Curia cGMP Process Development Introduction
11.17.4 Curia Revenue in cGMP Process Development Business (2021–2026)
11.17.5 Curia Recent Development
11.18 Almac Pharma Services
11.18.1 Almac Pharma Services Company Details
11.18.2 Almac Pharma Services Business Overview
11.18.3 Almac Pharma Services cGMP Process Development Introduction
11.18.4 Almac Pharma Services Revenue in cGMP Process Development Business (2021–2026)
11.18.5 Almac Pharma Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global cGMP Process Development Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Microbial cGMP Manufacturing
Table 3. Key Players of Mammalian cGMP Manufacturing
Table 4. Key Players of Others
Table 5. Global cGMP Process Development Market Size Growth Rate by Service Phase (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Preclinical Process Development
Table 7. Key Players of Clinical-Stage Process Development
Table 8. Key Players of Commercialization Process Development
Table 9. Global cGMP Process Development Market Size Growth Rate by Technology Platform (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Chemical Synthesis Process Development Platform
Table 11. Key Players of Cell Culture Process Development Platform
Table 12. Key Players of Others
Table 13. Global cGMP Process Development Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global cGMP Process Development Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global cGMP Process Development Market Size by Region (US$ Million), 2021–2026
Table 16. Global cGMP Process Development Market Share by Region (2021–2026)
Table 17. Global cGMP Process Development Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global cGMP Process Development Market Share by Region (2027–2032)
Table 19. cGMP Process Development Market Trends
Table 20. cGMP Process Development Market Drivers
Table 21. cGMP Process Development Market Challenges
Table 22. cGMP Process Development Market Restraints
Table 23. Global cGMP Process Development Revenue by Players (US$ Million), 2021–2026
Table 24. Global cGMP Process Development Market Share by Players (2021–2026)
Table 25. Global Top cGMP Process Development Players by Tier (Tier 1, Tier 2, and Tier 3), based on cGMP Process Development Revenue, 2025
Table 26. Ranking of Global Top cGMP Process Development Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by cGMP Process Development Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of cGMP Process Development, Headquarters and Area Served
Table 29. Global Key Players of cGMP Process Development, Products and Applications
Table 30. Global Key Players of cGMP Process Development, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global cGMP Process Development Market Size by Type (US$ Million), 2021–2026
Table 33. Global cGMP Process Development Revenue Market Share by Type (2021–2026)
Table 34. Global cGMP Process Development Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global cGMP Process Development Revenue Market Share by Type (2027–2032)
Table 36. Global cGMP Process Development Market Size by Application (US$ Million), 2021–2026
Table 37. Global cGMP Process Development Revenue Market Share by Application (2021–2026)
Table 38. Global cGMP Process Development Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global cGMP Process Development Revenue Market Share by Application (2027–2032)
Table 40. North America cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America cGMP Process Development Market Size by Country (US$ Million), 2021–2026
Table 42. North America cGMP Process Development Market Size by Country (US$ Million), 2027–2032
Table 43. Europe cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe cGMP Process Development Market Size by Country (US$ Million), 2021–2026
Table 45. Europe cGMP Process Development Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific cGMP Process Development Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific cGMP Process Development Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific cGMP Process Development Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America cGMP Process Development Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America cGMP Process Development Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa cGMP Process Development Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa cGMP Process Development Market Size by Country (US$ Million), 2027–2032
Table 55. Lonza Company Details
Table 56. Lonza Business Overview
Table 57. Lonza cGMP Process Development Product
Table 58. Lonza Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 59. Lonza Recent Development
Table 60. Thermo Fisher Scientific Company Details
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific cGMP Process Development Product
Table 63. Thermo Fisher Scientific Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Catalent Company Details
Table 66. Catalent Business Overview
Table 67. Catalent cGMP Process Development Product
Table 68. Catalent Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 69. Catalent Recent Development
Table 70. Samsung Biologics Company Details
Table 71. Samsung Biologics Business Overview
Table 72. Samsung Biologics cGMP Process Development Product
Table 73. Samsung Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 74. Samsung Biologics Recent Development
Table 75. WuXi Biologics Company Details
Table 76. WuXi Biologics Business Overview
Table 77. WuXi Biologics cGMP Process Development Product
Table 78. WuXi Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 79. WuXi Biologics Recent Development
Table 80. FUJIFILM Diosynth Biotechnologies Company Details
Table 81. FUJIFILM Diosynth Biotechnologies Business Overview
Table 82. FUJIFILM Diosynth Biotechnologies cGMP Process Development Product
Table 83. FUJIFILM Diosynth Biotechnologies Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 84. FUJIFILM Diosynth Biotechnologies Recent Development
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim cGMP Process Development Product
Table 88. Boehringer Ingelheim Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 89. Boehringer Ingelheim Recent Development
Table 90. Recipharm Company Details
Table 91. Recipharm Business Overview
Table 92. Recipharm cGMP Process Development Product
Table 93. Recipharm Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 94. Recipharm Recent Development
Table 95. Siegfried Company Details
Table 96. Siegfried Business Overview
Table 97. Siegfried cGMP Process Development Product
Table 98. Siegfried Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 99. Siegfried Recent Development
Table 100. Cambrex Company Details
Table 101. Cambrex Business Overview
Table 102. Cambrex cGMP Process Development Product
Table 103. Cambrex Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 104. Cambrex Recent Development
Table 105. WuXi STA Company Details
Table 106. WuXi STA Business Overview
Table 107. WuXi STA cGMP Process Development Product
Table 108. WuXi STA Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 109. WuXi STA Recent Development
Table 110. Piramal Pharma Solutions Company Details
Table 111. Piramal Pharma Solutions Business Overview
Table 112. Piramal Pharma Solutions cGMP Process Development Product
Table 113. Piramal Pharma Solutions Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 114. Piramal Pharma Solutions Recent Development
Table 115. Evonik Health Care Company Details
Table 116. Evonik Health Care Business Overview
Table 117. Evonik Health Care cGMP Process Development Product
Table 118. Evonik Health Care Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 119. Evonik Health Care Recent Development
Table 120. AGC Biologics Company Details
Table 121. AGC Biologics Business Overview
Table 122. AGC Biologics cGMP Process Development Product
Table 123. AGC Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 124. AGC Biologics Recent Development
Table 125. Rentschler Biopharma Company Details
Table 126. Rentschler Biopharma Business Overview
Table 127. Rentschler Biopharma cGMP Process Development Product
Table 128. Rentschler Biopharma Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 129. Rentschler Biopharma Recent Development
Table 130. KBI Biopharma Company Details
Table 131. KBI Biopharma Business Overview
Table 132. KBI Biopharma cGMP Process Development Product
Table 133. KBI Biopharma Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 134. KBI Biopharma Recent Development
Table 135. Curia Company Details
Table 136. Curia Business Overview
Table 137. Curia cGMP Process Development Product
Table 138. Curia Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 139. Curia Recent Development
Table 140. Almac Pharma Services Company Details
Table 141. Almac Pharma Services Business Overview
Table 142. Almac Pharma Services cGMP Process Development Product
Table 143. Almac Pharma Services Revenue in cGMP Process Development Business (US$ Million), 2021–2026
Table 144. Almac Pharma Services Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Authors List of This Report
List of Figures
Figure 1. cGMP Process Development Picture
Figure 2. Global cGMP Process Development Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global cGMP Process Development Market Share by Type: 2025 vs 2032
Figure 4. Microbial cGMP Manufacturing Features
Figure 5. Mammalian cGMP Manufacturing Features
Figure 6. Others Features
Figure 7. Global cGMP Process Development Market Size Comparison by Service Phase (US$ Million), 2021–2032
Figure 8. Preclinical Process Development Features
Figure 9. Clinical-Stage Process Development Features
Figure 10. Commercialization Process Development Features
Figure 11. Global cGMP Process Development Market Size Comparison by Technology Platform (US$ Million), 2021–2032
Figure 12. Chemical Synthesis Process Development Platform Features
Figure 13. Cell Culture Process Development Platform Features
Figure 14. Others Features
Figure 15. Global cGMP Process Development Market Size by Application (US$ Million), 2021–2032
Figure 16. Global cGMP Process Development Market Share by Application: 2025 vs 2032
Figure 17. Pharmaceutical Case Studies
Figure 18. Biotechnology Case Studies
Figure 19. Others Case Studies
Figure 20. cGMP Process Development Report Years Considered
Figure 21. Global cGMP Process Development Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global cGMP Process Development Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global cGMP Process Development Market Share by Region: 2025 vs 2032
Figure 24. Global cGMP Process Development Market Share by Players in 2025
Figure 25. Global cGMP Process Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by cGMP Process Development Revenue in 2025
Figure 27. North America cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America cGMP Process Development Market Share by Country (2021–2032)
Figure 29. United States cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe cGMP Process Development Market Share by Country (2021–2032)
Figure 33. Germany cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific cGMP Process Development Market Share by Region (2021–2032)
Figure 41. China cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America cGMP Process Development Market Share by Country (2021–2032)
Figure 49. Mexico cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa cGMP Process Development Market Share by Country (2021–2032)
Figure 53. Israel cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Lonza Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 58. Catalent Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 59. Samsung Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 60. WuXi Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 61. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 63. Recipharm Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 64. Siegfried Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 65. Cambrex Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 66. WuXi STA Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 67. Piramal Pharma Solutions Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 68. Evonik Health Care Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 69. AGC Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 70. Rentschler Biopharma Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 71. KBI Biopharma Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 72. Curia Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 73. Almac Pharma Services Revenue Growth Rate in cGMP Process Development Business (2021–2026)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
